G
GENPACT LTD
GENPACT LTD historical holders
total: 7
Jensen Investment Management GENPACT LTD transactions over time
- Total transactions:
- 12
- New positions:
- 1
- Added:
- 8
- Reduced:
- 3
- Held since:
- 2022 Q2
- Held for:
- 16 quarters
- Latest activity:
- 2026 Q1
Eric H. Schoenstein has been an institutional investor in GENPACT LTD (G) since 2022 Q2. According to 2026 Q1 report, Eric H. Schoenstein holds 92,985 shares with a market value of roughly $3.46M representing 0.07% of their equity portfolio. The fund/company first acquired G in 2022 Q2, initially purchasing 106,380 shares. Since the initial investment, Jensen Investment Management has made 11 more transactions in this position.
Does Eric H. Schoenstein still hold G?
Yes, Eric H. Schoenstein continues to hold GENPACT LTD (G). According to their 2026 Q1 report, they maintain a position of 92,985 shares valued at approximately $3.46M, representing 0.07% of their equity portfolio.
When did Eric H. Schoenstein first invest in G?
Eric H. Schoenstein first invested in GENPACT LTD (G) in 2022 Q2 at the reported quarter-end price of $42.36 per share, acquiring 106,380 shares in their initial purchase.
What is Eric H. Schoenstein's average cost basis for G?
Based on historical transaction data, Eric H. Schoenstein's estimated cost basis for GENPACT LTD (G) is approximately $39.88 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $39.88
- Weighted AVG sell price:
- $45.02
G transactions history by Jensen Investment Management
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.07%
|
92,985
|
$37.25
|
$3,463,691
|
-20.27% (-23,640)
|
-0.01%
|
|
2025 Q3
|
0.06%
|
116,625
|
$41.89
|
$4,885,421
|
-21.30% (-31,570)
|
-0.02%
|
|
2025 Q2
|
0.08%
|
148,195
|
$44.01
|
$6,522,062
|
+3.83% (+5,460)
|
+0%
|
|
2025 Q1
|
0.08%
|
142,735
|
$50.38
|
$7,190,989
|
-26.98% (-52,750)
|
-0.02%
|
|
2024 Q4
|
0.08%
|
195,485
|
$42.95
|
$8,396,081
|
+2.89% (+5,500)
|
+0%
|
|
2024 Q3
|
0.06%
|
189,985
|
$39.21
|
$7,449,312
|
+6.39% (+11,410)
|
+0%
|
|
2024 Q1
|
0.04%
|
178,575
|
$32.95
|
$5,884,046
|
+16.66% (+25,505)
|
+0.01%
|
|
2023 Q4
|
0.04%
|
153,070
|
$34.71
|
$5,313,060
|
+5.14% (+7,480)
|
+0%
|
|
2023 Q3
|
0.04%
|
145,590
|
$36.20
|
$5,270,358
|
+12.42% (+16,080)
|
+0%
|
|
2023 Q2
|
0.04%
|
129,510
|
$37.57
|
$4,865,691
|
+17.29% (+19,090)
|
+0.01%
|
|
2023 Q1
|
0.04%
|
$45.52
|
+3.80% (+4,040)
|
|||
|
2022 Q2
|
0.04%
|
$42.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.